![Nathan Stasko](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Nathan Stasko was the founder of NVN Liquidation, Inc. since 2006, serving as President, Director & Chief Scientific Officer from 2017 to 2019.
Dr. Stasko is currently the Chief Executive Officer & Director at Vast Therapeutics, Inc. since 2022.
Formerly, Dr. Stasko was a Director at KNOW Bio LLC.
Postes actifs de Nathan Stasko
| Sociétés | Poste | Début |
|---|---|---|
Vast Therapeutics, Inc.
 Vast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a preclinical stage biotechnology company which develops inhalable therapeutics to treat chronic infections | Directeur Général | 01/03/2022 |
Anciens postes connus de Nathan Stasko
| Sociétés | Poste | Fin |
|---|---|---|
| NVN LIQUIDATION, INC. | Directeur Général | 05/06/2017 |
KNOW Bio LLC
 KNOW Bio LLC Pharmaceuticals: MajorHealth Technology Develops and produces nitric oxide-based therapies | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
24
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
NVN Liquidation, Inc.
 NVN Liquidation, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops treatment for nitric oxide’s immunomodulatory & anti microbial mechanisms | Health Technology |
KNOW Bio LLC
KNOW Bio LLC Pharmaceuticals: MajorHealth Technology Develops and produces nitric oxide-based therapies | Health Technology |
Vast Therapeutics, Inc.
Vast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a preclinical stage biotechnology company which develops inhalable therapeutics to treat chronic infections | Health Technology |
